ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,329.88
1.10%
S&P 500
5,241.69
-0.48%
Dow Jones
38,055.10
-1.01%
US Dollar vs Yen
156.631
-0.62%
Brent Oil
82.815
-0.67%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. カナダ
  5. TSXV
  6. Diamedica Therapeutics (DMA)

  7. Diamedica Therapeutics (DMA) ニュース

DMA

DiaMedica Inc. (DMA)

Diamedica Therapeutics
から:
次の項目別のソート:
 Showing the most relevant articles for your search:TSXV:DMA
日付受信時刻ニュースソース見出しコード企業名
2014/07/3021 : 00Marketwired CanadaDiaMedica to Present at InvestMNt Conference on August 6, 2014TSXV:DMADiamedica Therapeutics
2014/07/2605 : 30Marketwired CanadaDiaMedica Inc. Announces Results of Annual General and Special Meeting of ShareholdersTSXV:DMADiamedica Therapeutics
2014/07/1021 : 30Marketwired CanadaDiaMedica Promotes Mark Robbins to Executive Vice PresidentTSXV:DMADiamedica Therapeutics
2014/07/0906 : 09Marketwired CanadaDiaMedica Announces Stock Option GrantTSXV:DMADiamedica Therapeutics
2014/07/0721 : 30Marketwired CanadaDiaMedica Appoints Rich Pilnik as Chairman of the Board of DirectorsTSXV:DMADiamedica Therapeutics
2014/06/1020 : 30Marketwired CanadaDiaMedica to Present Clinical Abstract on DM199 at the 74th Annual American Diabetes Association ConferenceTSXV:DMADiamedica Therapeutics
2014/06/1020 : 30MarketwiredDiaMedica to Present Clinical Abstract on DM199 at the 74th Annual American Diabetes Association ConferenceTSXV:DMADiamedica Therapeutics
2014/06/0523 : 22Marketwired CanadaDiaMedica Announces Development UpdateTSXV:DMADiamedica Therapeutics
2014/06/0523 : 22MarketwiredDiaMedica Announces Development UpdateTSXV:DMADiamedica Therapeutics
2014/06/0323 : 56Marketwired CanadaDiaMedica Inc. Appoints Dr. Ralph A. DeFronzo to its Scientific Advisory BoardTSXV:DMADiamedica Therapeutics
2014/06/0323 : 56MarketwiredDiaMedica Inc. Appoints Dr. Ralph A. DeFronzo to its Scientific Advisory BoardTSXV:DMADiamedica Therapeutics
2014/05/2800 : 53Marketwired CanadaDiaMedica Announces Completion of Prospectus OfferingTSXV:DMADiamedica Therapeutics
2014/05/2105 : 22Marketwired CanadaDiaMedica Inc. Announces Filing of Final ProspectusTSXV:DMADiamedica Therapeutics
2014/05/1307 : 26Marketwired CanadaDiaMedica Inc. Finalizes Terms of Public OfferingTSXV:DMADiamedica Therapeutics
2014/05/0820 : 05Marketwired CanadaDiaMedica Inc. Provides Update on Public OfferingTSXV:DMADiamedica Therapeutics
2014/04/2606 : 50Marketwired CanadaDiaMedica Inc. Amends the Expiry Date of WarrantsTSXV:DMADiamedica Therapeutics
2014/04/2305 : 05Marketwired CanadaDiaMedica Inc. Announces Public OfferingTSXV:DMADiamedica Therapeutics
2014/04/1722 : 28Marketwired CanadaDiaMedica Inc. to Amend the Expiry Date of WarrantsTSXV:DMADiamedica Therapeutics
2014/04/1522 : 00Marketwired CanadaDiaMedica to Present at the 2014 GTC Diabetes SummitTSXV:DMADiamedica Therapeutics
2014/04/1522 : 00MarketwiredDiaMedica to Present at the 2014 GTC Diabetes SummitTSXV:DMADiamedica Therapeutics
2014/04/0722 : 07MarketwiredDiaMedica Appoints John Savage as Chief Financial OfficerTSXV:DMADiamedica Therapeutics
2014/04/0722 : 06Marketwired CanadaDiaMedica Appoints John Savage as Chief Financial OfficerTSXV:DMADiamedica Therapeutics
2014/03/2601 : 14Marketwired CanadaGranite Creek Cancels Consulting AgreementTSXV:DMADiamedica Therapeutics
2014/02/1922 : 30MarketwiredDiaMedica Files 20-F Registration Statement with U.S. SEC and Provides Clinical UpdateTSXV:DMADiamedica Therapeutics
2014/02/1921 : 30Marketwired CanadaDiaMedica Files 20-F Registration Statement with U.S. SEC and Provides Clinical UpdateTSXV:DMADiamedica Therapeutics
2014/02/0602 : 15MarketwiredDiaMedica to Present at 16th Annual BIO CEO & Investor ConferenceTSXV:DMADiamedica Therapeutics
2014/02/0601 : 15Marketwired CanadaDiaMedica to Present at 16th Annual BIO CEO & Investor ConferenceTSXV:DMADiamedica Therapeutics
2014/01/2307 : 10Marketwired CanadaDiaMedica Inc. Announces Partial Exercise of Over-Allotment OptionTSXV:DMADiamedica Therapeutics
2014/01/0922 : 30MarketwiredDiaMedica Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of DM199 in Type 2 Diabetic PatientsTSXV:DMADiamedica Therapeutics
2014/01/0921 : 30Marketwired CanadaDiaMedica Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of DM199 in Type 2 Diabetic PatientsTSXV:DMADiamedica Therapeutics
 Showing the most relevant articles for your search:TSXV:DMA

最近閲覧した銘柄

BIT
F30661
Vontobel Financial Produ...
BIT
S32120
Societe Generale Effekten
BIT
P1RII1
BNP Paribas Issuance
COIN
ZYDBTC
BIT
P1OKJ2
BNP Paribas Issuance
BIT
P1STI6
BNP Paribas Issuance
BIT
P1T8P1
BNP Paribas Issuance
NYSE
GEB.CL
TSXV
RPL
LBNK
SQUIDGROWUSDT
SquidGrow
BIT
P1U6F3
BNP Paribas Issuance
BIT
P1TY27
BNP Paribas Issuance
BIT
F38525
Vontobel Financial Produ...
BIT
P1PII5
BNP Paribas Issuance
BIT
F38455
Vontobel Financial Produ...
BIT
P1TYG8
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有